Andromeda Surgical

Andromeda Surgical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Andromeda Surgical is a private, pre-revenue company pioneering an open, AI-driven surgical robotics platform. Founded in 2023 by entrepreneurs with deep expertise in medtech and autonomous systems, the company has already achieved a clinical milestone with the world's first robotic-assisted HoLEP procedure. By forging strategic partnerships with established medical device companies and leveraging a continuous software-update model, Andromeda aims to scale from urology into a multi-specialty platform that democratizes expert-level surgical care.

Urology

Technology Platform

Open, software-centric surgical platform featuring AI-guided spatial navigation ("Google Maps for the Human Body") and surgeon-in-the-loop autonomous task capabilities. It uses an iPad interface and integrates with existing surgical tools.

Opportunities

The company targets the large and growing surgical robotics market with a disruptive, lower-cost, software-focused platform that could democratize access to robotic assistance.
Its open architecture and AI-driven efficiency gains address key healthcare economic pressures around cost, training, and surgical throughput.

Risk Factors

Key risks include the significant technical and regulatory hurdles of developing safe and effective autonomous surgical AI, competition from large, well-funded incumbents and new entrants in surgical robotics, and the financial dependency on venture funding as a pre-revenue company.

Competitive Landscape

Andromeda enters a competitive market dominated by Intuitive Surgical, with major medtech players like Medtronic, Johnson & Johnson, and CMR Surgical also launching advanced robotic platforms. Its differentiation lies in its open, software-first approach, iPad-based interface, and focus on progressive autonomy rather than hardware complexity.